Product Information

RIVASTIGMINE 4.5 MG CAPSULE is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.1706 per EA under NDC 55111035460. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Oct 31, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIVASTIGMINE 4.5 MG CAPSULE

Rivastigmine Tartrate
$0.1706per EA

Strength

4.5 mg/1

NDC

55111035460

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

RIVASTIGMINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA077130

FDA Approved

10/31/2007

TE Code

AB

On Market Since

9/1/2011

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price Statistics

The NADAC for RIVASTIGMINE 4.5 MG CAPSULE has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 89.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1706 per EA
All-time high$1.9894 (Mar 12, 2014)
All-time low$0.1706 (Oct 21, 2026)
52-week high$0.2100
52-week low$0.1706
Median price$0.3699
Average price$0.6643
Largest weekly change+103.3% (Jan 20, 2021)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-2.2%

3M

-8.8%

6M

-14.3%

1Y

-8.8%

3Y

-25.6%

5Y

-41.8%

All

-89.8%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RIVASTIGMINE 4.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 4.5 MG CAPSULE, manufactured by Dr. Reddy's Laboratories Inc., is $0.1706 per EA (NDC 55111035460), effective Nov 11, 2026.

How has the price of RIVASTIGMINE 4.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for RIVASTIGMINE 4.5 MG CAPSULE has declined 89.8%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 4.5 MG CAPSULE?

Since Nov 28, 2013, the NADAC for RIVASTIGMINE 4.5 MG CAPSULE has ranged from a low of $0.1706 (Oct 21, 2026) to a high of $1.9894 (Mar 12, 2014), with a median of $0.3699 per EA.

Are there cheaper alternatives to RIVASTIGMINE 4.5 MG CAPSULE?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIVASTIGMINE 4.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures RIVASTIGMINE 4.5 MG CAPSULE?

RIVASTIGMINE 4.5 MG CAPSULE (NDC 55111035460) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.